Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

被引：0
|
作者：
Daniel M. Huse
Margaret von Mehren
Gregory Lenhart
Heikki Joensuu
Charles Blanke
Weiwei Feng
Stan Finkelstein
George Demetri
机构：
[1] Thomson Medstat,Department of Medical Oncology
[2] Fox Chase Cancer Center,Department of Oncology, Helsinki University
[3] Helsinki University Central Hospital,MIT Sloan School of Management
[4] The Oregon Health and Science University Cancer Institute,Dana
[5] Novartis Pharmaceuticals Corporation,Farber Cancer Institute
[6] Oncology,undefined
[7] Harvard-MIT Division of Health Sciences and Technology,undefined
[8] Center for Sarcoma and Bone Oncology,undefined
来源：
Clinical Drug Investigation | 2007年 / 27卷
关键词：
Pancreatic Cancer; Imatinib; National Comprehensive Cancer Network; National Comprehensive Cancer Network; Imatinib Mesylate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is partly dependent on reimbursement by third-party payers in many countries. The objective of this study was to estimate the cost effectiveness of imatinib mesylate in the treatment of GIST.
引用
收藏
页码：85 / 93
页数：8
相关论文
共 50 条
  • [31] Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor
    Ying-Yong Hou
    World Journal of Gastroenterology, 2009, 15 (15) : 1910 - 1913
  • [32] One institutional experience with imatinib mesylate in the treatment of gastrointestinal stromal tumors
    Tamas, Karin R.
    Papai, Zsuzsa
    Vegh, Eva A.
    Petranyi, Agota E.
    Szucs, Zoltan
    Rohanszky, Magda
    Aranyi, Zsuzsa
    Bodoky, Gyorgy
    ANNALS OF ONCOLOGY, 2006, 17 : 164 - 164
  • [33] Is there a role for post-imatinib surgery in advanced gastrointestinal stromal tumours?
    Kuhlmann, K. F. D.
    Kerst, J. M.
    Cats, A.
    van Coevorden, F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A3 - A3
  • [34] Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib
    Tielen, R.
    Verhoef, C.
    van Coevorden, F.
    Gelderblom, H.
    Sleijfer, S.
    Hartgrink, H. H.
    Bonenkamp, J. J.
    van der Graaf, W. T. A.
    de Wilt, J. H. W.
    EJSO, 2013, 39 (02): : 150 - 155
  • [35] Verification of imatiNib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE)
    Mabasa, V.
    Taylor, S. C.
    Chu, C. C.
    Moravan, V.
    Peacock, S.
    Knowling, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Use of imatinib mesylate in gastrointestinal stromal tumours:: Pan-Birmingham Cancer Network Experience
    Wong, D. W. Y.
    Lupton, S. C.
    Bhatt, L.
    Gross, L.
    Taniere, P.
    Peake, D. R.
    Spooner, D.
    Geh, J. I.
    CLINICAL ONCOLOGY, 2008, 20 (07) : 517 - 522
  • [37] The risk of hepatitis B virus (HBV) reactivation in patients with gastrointestinal stromal tumours (GIST) under imatinib mesylate treatment
    Soufleris, K.
    Lazaraki, G.
    Pavlioglou, P.
    Stergiou, E.
    Paraskevaidou, K.
    Tzilves, D.
    ANNALS OF ONCOLOGY, 2019, 30 : 96 - 96
  • [38] The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness
    Kosmadakis, N
    Visvardis, EE
    Kartsaklis, P
    Tsimara, M
    Chatziantoniou, A
    Panopoulos, L
    Erato, P
    Capsambelis, P
    SURGICAL ONCOLOGY-OXFORD, 2005, 14 (02): : 75 - 84
  • [39] Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: A report of two cases
    Hasan, S
    Hassan, M
    Oke, L
    Dinh, K
    Onojobi, G
    Lombardo, F
    Dawkins, F
    Jack, M
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (12) : 1208 - 1210
  • [40] Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
    Fiore, M.
    Palassini, E.
    Fumagalli, E.
    Pilotti, S.
    Tamborini, E.
    Stacchiotti, S.
    Pennacchioli, E.
    Casali, P. G.
    Gronchi, A.
    EJSO, 2009, 35 (07): : 739 - 745
12345